Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids

Fig. 3

Immunohistochemistry for markers of alveolar type II cells and AAV entry receptors. Representative images are shown of fixed-frozen sections of LBOs (n = 2–3), with nuclei stained with DAPI (blue) and various markers (red), including ATII cell marker SP-C (a), ATII cell marker SP-B (b, c), universal AAV co-receptor AAVR (d), glycan receptor α-2,3-linked sialic acid (e, f) and glycan receptor heparan sulphate (g, h). Native fluorescence is observed following microinjection of AAV6.2-CMV-eGFP (c) compared with negative control LBOs (b). Sections digested with sialidase A (e) and heparinase III (g) to remove glycans are included as negative staining controls. Staining controls for images ad are shown in suppl. Fig. 2. Scale bar 50 μm

Back to article page